J Liver Cancer.  2020 Sep;20(2):106-112. 10.17998/jlc.20.2.106.

Prognostic Significance of Preoperative Controlling Nutritional Status Score in Patients Who Underwent Hepatic Resection for Hepatocellular Carcinoma

• Kim BS

• KMID: 2508021
• DOI: http://doi.org/10.17998/jlc.20.2.106

Abstract

Malnutrition is common in patients with hepatocellualar carcinoma (HCC), and is associated with postoperative complications after hepatectomy, and also increased mortality. However, there is currently no recommendation for assessment of nutritional status in HCC patients. The controlling nutritional status (CONUT) score has been correlated with prognosis in gastrointestinal cancer patients, but there are few reports on the prognostic significance of the CONUT score in patients who underwent hepatectomy for HCC. Existing results show that patients with high CONUT scores who undergo hepatectomy for HCC have poorer survival outcomes, and experience more complications than other patients. In this paper, we review the literature, and reveal that patients who underwent hepatectomy for HCC with high preoperative CONUT scores had poorer outcomes than those with low CONUT scores. Therefore, we conclude that a preoperative CONUT score may be useful for prognostic prediction in patients with HCC undergoing curative hepatectomy.

Keyword

Controlling nutritional status score; Hepatocellular carcinoma; Outcomes

Reference

1. Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013; 132:1133–1145.

2. Alberino F, Gatta A, Amodio P, Merkel C, Di Pascoli L, Boffo G, et al. Nutrition and survival in patients with liver cirrhosis. Nutrition. 2001; 17:445–450.

3. Takenaka K, Kawahara N, Yamamoto K, Kajiyama K, Maeda T, Itasaka H, et al. Results of 280 liver resections for hepatocellular carcinoma. Arch Surg. 1996; 131:71–76.

4. Taketomi A, Kitagawa D, Itoh S, Harimoto N, Yamashita Y, Gion T, et al. Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute’s experience with 625 patients. J Am Coll Surg. 2007; 204:580–587.

5. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012; 379:1245–1255.

6. Huitzil-Melendez FD, Capanu M, O’Reilly EM, Duffy A, Gansukh B, Saltz LL, et al. Advanced hepatocellular carcinoma: which staging systems best predict prognosis? J Clin Oncol. 2010; 28:2889–2895.

7. The Cancer of the Liver Italian Program (Clip) Investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology. 1998; 28:751–755.

8. Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999; 19:329–338.

9. Man Z, Pang Q, Zhou L, Wang Y, Hu X, Yang S, et al. Prognostic significance of preoperative prognostic nutritional index in hepatocellular carcinoma: a meta-analysis. HPB (Oxford). 2018; 20:888–895.

10. Chan AW, Chan SL, Wong GL, Wong VW, Chong CC, Lai PB, et al. Prognostic nutritional index (PNI) predicts tumor recurrence of very early/early stage hepatocellular carcinoma after surgical resection. Ann Surg Oncol. 2015; 22:4138–4148.

11. Okamura Y, Ashida R, Ito T, Sugiura T, Mori K, Uesaka K. Preoperative neutrophil to lymphocyte ratio and prognostic nutritional index predict overall survival after hepatectomy for hepatocellular carcinoma. World J Surg. 2015; 39:1501–1509.

12. Baracos VE. Cancer-associated malnutrition. Eur J Clin Nutr. 2018; 72:1255–1259.

13. Alwarawrah Y, Kiernan K, MacIver NJ. Changes in nutritional tatus impact immune cell metabolism and function. Front Immunol. 2018; 9:1055.

14. Lien YC, Hsieh CC, Wu YC, Hsu HS, Hsu WH, Wang LS, et al. Preoperative serum albumin level is a prognostic indicator for adenocarcinoma of the gastric cardia. J Gastointest Surg. 2004; 8:1041–1048.

15. Ray-Coquard I, Cropet C, Van Glabbeke M, Sebban C, Le Cesne A, Judson I, et al. Lymphopenia as a prognostic factor for overall in advanced carcinomas, sarcomas, and lymphomas. Cancer Res. 2009; 69:5383–5391.

16. Schwegler I, von Holzen A, Gutzwiller JP, Schlumpf R, Mühlebach S, Stanga Z. Nutritional risk is a clinical predictor of postoperative mortality and morbidity in surgery for colorectal cancer. Br J Surg. 2010; 97:92–97.

17. Bozzetti F, Mariani L, Lo Vullo S, Amerio ML, Biffi R, Caccialanza G, et al. The nutritional risk in oncology: a study of 1,453 cancer outpatients. Support Care Cancer. 2012; 20:1919–1928.

18. Jensen GL, Bistrian B, Roubenoff R, Heimburger DC. Malnutrition syndromes: a conundrum vs continuum. J Parenter Enteral Nutr. 2009; 33:710–716.

19. Montano-Loza AJ, Duarte-Rojo A, Meza-Junco J, Baracos VE, Sawyer MB, Pang JXQ, et al. Inclusion of Sarcopenia within MELD (MELD-sarcopenia) and the prediction of mortality in patients with cirrhosis. Clin Transl Gastroenterol. 2015; 6:e102.

20. Calmet F, Martin P, Pearlman M. Nutrition in patients with cirrhosis. Gastroenterol Hepatol (N Y). 2019; 15:248–254.

21. Schütte K, Tippelt B, Schulz C, Röhl F, Feneberg A, Seidensticker R, et al. Malnutrition is a prognostic factor in patients with hepatocellular carcinoma (HCC). Clin Nutr. 2015; 34:1122–1127.

22. Huang TH, Hsieh CC, Kuo LM, Chang C, Chen C, Chi C, et al. Malnutrition associated with an increased risk of postoperative complications following hepatectomy in patients with hepatocellular carcinoma. HPB (Oxford). 2019; 21:1150–1155.

23. Ciuni R, Biondi A, Grosso G, Nunnari G, Panascia E, Randisi L, et al. Nutritional aspects in patient undergoing liver resection. Updates Surg. 2011; 63:249–252.

24. Kawaguchi T, Taniguchi E, Itou M, Ibi R, Okada T, Mutou M, et al. Body cell mass is a useful parameter for assessing malnutrition and severity of disease in non-ascitic cirrhotic patients with hepatocellular carcinoma or esophageal varices. Int J Mol Med. 2008; 22:589–594.

25. Alvares-da-Silva MR, Reverbel da Silveira T. Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients. Nutrition. 2005; 21:113–117.

26. Schütte K, Tippelt B, Schulz C, Röhl FW, Feneberg A, Seidensticker R, et al. Malnutrition is a prognostic factor in patients with hepatocellular carcinoma (HCC). Clin Nutr. 2015; 34:1122–1127.

27. Kondrup J, Rasmussen HH, Hamberg O, Stanga Z. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr. 2003; 22:321–336.

28. Sorensen J, Kondrup J, Prokopowicz J, Schiesser M, Krahenbühl L, Meier R, et al. EuroOOPS: an international, multicentre study to implement nutritional risk screening and evaluate clinical outcome. Clin Nutr. 2008; 27:340–349.

29. Vellas B, Guigoz Y, Garry PJ, Nourhashemi F, Bennahum D, Lauque S, et al. The mini nutritional assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrtion. 1999; 15:116–122.

30. Tsai AC, Hsu W, Chan S, Chang T. Usefulness of the mini nutritional assessment in predicting the nutritional status of patients with liver cancer in Taiwan. Nutr Cancer. 2011; 63:334–341.

31. Jiang N, Deng JY, Ding XW, Ke B, Ning Liu, Zhang RP, et al. Prognostic nutritional index predicts postoperative complications and long-term outcomes of gastric cancer. World J Gastroenterol. 2014; 20:10537–10544.

32. Pinato DJ, North BV, Sharma R. A novel, externally validated inflammation based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI). Br J Canc. 2012; 106:1439–1445.

33. Ke M, Xu T, Li N, Ren Y, Shi A, Lv Y, et al. Prognostic nutritional index predicts short-term outcomes after liver resection for hepatocellular carcinoma within the Milan criteria. Oncotarget. 2016; 7:81611–81620.

34. Iseki Y, Shibutani M, Maeda K, Nagahara H, Ohtani H, Sugano K, et al. Impact of the preoperative controlling nutritional status (CONUT) score on the survival after curative surgery for colorectal cancer. PLoS One. 2015; 10:e0132488.

35. Ignacio de Ulíbarri J, González-Madroño A, de Villar NG, González P, González B, Mancha A, et al. CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp. 2005; 20:38–45.

36. Oñate-Ocaña LF, Aiello-Crocifoglio V, Gallardo-Rincón D, Herrera-Goepfert R, Brom-Valladares R, Carrillo JF, et al. Serum albumin as a significant prognostic factor for patients with gastric carcinoma. Ann Surg Oncol. 2007; 14:381–389.

37. Lu SD, Wang YY, Peng NF, Peng YC, Zhong JH, Qin HG, et al. Preoperative ratio of neutrophils to lymphocytes predicts postresection survival in selected patients with early or intermediate stage hepatocellular carcinoma. Medicine (Baltimore). 2016; 95:e2722.

38. Jiang SS, Weng DS, Jiang L, Zhang YJ, Pan K, Pan QZ, et al. The clinical significance of preoperative serum cholesterol and high-density lipoprotein-cholesterol levels in hepatocellular carcinoma. J Cancer. 2016; 7:626–632.

39. Lee YL, Li WC, Tsai TH, Chiang HY, Ting CT. Body mass index and cholesterol level predict surgical outcome in patients with hepatocellular carcinoma in Taiwan-a cohort study. Oncotarget. 2016; 7:22948–22959.

40. Lin ZX, Ruan DY, Jia CC, Wang TT, Cheng JT, Huang HQ, et al. Controlling nutritional status (CONUT) score-based nomogram to predict overall survival of patients with HBV-associated hepatocellular carcinoma after curative hepatectomy. Clin Transl Oncol. 2020; 22:370–380.

41. Takagi K, Yagi T, Umeda Y, Shinoura S, Yoshida R, Nobuoka D, et al. Preoperative controlling nutritional status (CONUT) score for assessment of prognosis following hepatectomy for hepatocellular carcinoma. World J Surg. 2017; 41:2353–2360.

42. Harimoto N, Yoshizumi T, Sakata K, Nagatsu A, Motomura T, Itoh S, et al. Prognostic significance of preoperative controlling nutritional status (CONUT) score in patients undergoing hepatic resection for hepatocellular carcinoma. World J Surg. 2017; 41:2805–2812.

43. Harimoto N, Yoshizumi T, Inokuchi S, Itoh S, Adachi E, Ikeda Y, et al. Prognostic significance of preoperative controlling nutritional status (CONUT) score in patients undergoing hepatic resection for hepatocellular carcinoma: a multi-institutional study. Ann Surg Oncol. 2018; 25:3316–3323.

44. Takagi K, Umeda Y, Yoshida R, Nobuoka D, Kuise T, Fushimi T, et al. Preoperative controlling nutritional status score predicts mortality after hepatectomy for hepatocellular carcinoma. Dig Surg. 2019; 36:226–232.

45. Li L, Liu C, Yang J, Wu H, Wen T, Wang W, et al. Early postoperative controlling nutritional status (CONUT) score is associated with complication III-V after hepatectomy in hepatocellular carcinoma: a retrospective cohort study of 1,334 patients. Sci Rep. 2018; 8:13406.

46. Wang XB, Chen J, Xiang BD, Wu FX, Li LQ. High CONUT score predicts poor survival and postoperative HBV reactivation in HBV-related hepatocellular carcinoma patients with low HBV-DNA levels. Eur J Surg Oncol. 2019; 45:782–787.

47. Liu C, Li L, Lu WS, Du H, Yan LN, Wen TF, et al. A novel combined systemic inflammation-based score can predict survival of intermediate-to-advanced hepatocellular carcinoma patients undergoing transarterial chemoembolization. BMC Cancer. 2018; 18:216.

48. Takagi K, Domagala P, Polak WG, Buettner S, Ijzermans JNM. The controlling nutritional status score and postoperative complication risk in gastrointestinal and hepatopancreatobiliary surgical oncology: a systematic review and meta-analysis. Ann Nutr Metab. 2019; 74:303–312.

49. Zhang Y, Zhang X. Controlling nutritional status score, a promising prognostic marker in patients with gastrointestinal cancers after surgery: a systematic review and meta-analysis. Int J Surg. 2018; 55:39–45.